Related Experiment Video
Updated: Jul 7, 2026
07:55
Establishment and Propagation of Human Retinoblastoma Tumors in Immune Deficient Mice
Published on: August 4, 2011
11.9K
Retinoblastoma: Review and new insights
Claudia Carolina Cruz-Gálvez1, Juan Carlos Ordaz-Favila2, Víctor Manuel Villar-Calvo3
1Physiology Department, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Mexico.
Frontiers in Oncology
|November 21, 2022
Summary
Retinoblastoma (Rb), a childhood eye cancer, stems from RB1 gene mutations. Early detection via the Bruckner test and new biomarkers are crucial for improving survival rates, especially in developing nations.
Area of Science:
- Ophthalmology
- Oncology
- Genetics
Background:
- Retinoblastoma (Rb) is the most common intraocular malignancy in children, caused by mutations in the RB1 gene on chromosome 13q14.2.
- Rb represents a model hereditary cancer, with 30-40% of cases exhibiting autosomal dominant inheritance and 60-70% being sporadic.
- Inactivation of both RB1 alleles leads to a non-functional pRB protein, causing cell cycle dysregulation and uncontrolled proliferation.
Purpose of the Study:
- To highlight the significance of early detection and diagnosis of retinoblastoma.
- To emphasize the need for novel, less toxic therapeutic strategies for Rb.
- To explore the potential of biomarkers for early detection and treatment of Rb.
Main Methods:
- The Bruckner test, assessing the red reflex for leukocoria, is a practical clinical diagnostic tool for Rb.
- Genetic analysis of the RB1 gene.
- Identification and validation of novel biomarkers for Rb detection and management.
Main Results:
- Rb diagnosis is primarily clinical, with the Bruckner test identifying leukocoria (white pupil) as a key sign.
- Survival rates for Rb exceed 95% in developed countries, but mortality remains high (e.g., 70% in Africa) in developing regions.
- Emerging biomarkers show promise for early molecular detection, micrometastasis identification, and new therapeutic avenues.
Conclusions:
- Early detection of retinoblastoma, through methods like the Bruckner test, is critical for improving patient outcomes.
- Addressing disparities in survival rates between developed and developing countries is essential.
- Biomarker research offers significant potential for advancing Rb diagnosis and treatment strategies.
Related Concept Videos
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...